These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17803331)

  • 41. Assessing the quality of healthcare provided to children.
    Mangione-Smith R; McGlynn EA
    Health Serv Res; 1998 Oct; 33(4 Pt 2):1059-90. PubMed ID: 9776949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economics of children's environmental health.
    Trasande L
    Mt Sinai J Med; 2011; 78(1):98-106. PubMed ID: 21259266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges.
    Lamsal R; Zwicker JD
    Appl Health Econ Health Policy; 2017 Dec; 15(6):763-772. PubMed ID: 28822113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cost-utility analysis; uncertainties restrict applicability].
    de Neeling JN
    Ned Tijdschr Geneeskd; 2004 May; 148(22):1106-10. PubMed ID: 15198066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm.
    Ratcliffe J; Huynh E; Chen G; Stevens K; Swait J; Brazier J; Sawyer M; Roberts R; Flynn T
    Soc Sci Med; 2016 May; 157():48-59. PubMed ID: 27060541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic evaluation in health care: is there a role for cost-benefit analysis?
    Johannesson M; Jönsson B
    Health Policy; 1991 Feb; 17(1):1-23. PubMed ID: 10113574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.
    Posnett J; Jan S
    Health Econ; 1996; 5(1):13-23. PubMed ID: 8653189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis.
    Grosse SD; Wordsworth S; Payne K
    Genet Med; 2008 Sep; 10(9):648-54. PubMed ID: 18978674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preference-based approaches to measuring the benefits of perinatal care.
    Petrou S; Henderson J
    Birth; 2003 Dec; 30(4):217-26. PubMed ID: 14992152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring, valuing and including forgone childhood education and leisure time costs in economic evaluation: Methods, challenges and the way forward.
    Andronis L; Maredza M; Petrou S
    Soc Sci Med; 2019 Sep; 237():112475. PubMed ID: 31408769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In or out? Income losses in health state valuations: a review.
    Tilling C; Krol M; Tsuchiya A; Brazier J; Brouwer W
    Value Health; 2010; 13(2):298-305. PubMed ID: 19804433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence-Based Medicine in Otolaryngology Part 9: Valuing Health Outcomes.
    Caulley L; Hunink MG; Kilty S; Metha V; Scangas G; Rodin D; Randolph G; Shin JJ
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):11-21. PubMed ID: 30252610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quality of life and its measurement in children].
    Kvrgić S; Nićiforović-Surković O
    Med Pregl; 2002; 55(1-2):57-9. PubMed ID: 12037941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities.
    McCabe C; Edlin R; Meads D; Brown C; Kharroubi S
    Pharmacoeconomics; 2013 Aug; 31(8):635-41. PubMed ID: 23832811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic evaluation in healthcare. A brief history and future directions.
    Blumenschein K; Johannesson M
    Pharmacoeconomics; 1996 Aug; 10(2):114-22. PubMed ID: 10163414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Considering consumer choice in the economic evaluation of mandatory health programmes: a review.
    Parkinson B; Goodall S
    Health Policy; 2011 Aug; 101(3):236-44. PubMed ID: 20961646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combining Health and Outcomes Beyond Health in Complex Evaluations of Complex Interventions: Suggestions for Economic Evaluation.
    Wildman J; Wildman JM
    Value Health; 2019 May; 22(5):511-517. PubMed ID: 31104728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Challenges in developing capability measures for children and young people for use in the economic evaluation of health and care interventions.
    Mitchell PM; Husbands S; Byford S; Kinghorn P; Bailey C; Peters TJ; Coast J
    Health Econ; 2021 Sep; 30(9):1990-2003. PubMed ID: 34036671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of health-Empirical issues when estimating the monetary value of a quality-adjusted life year based on well-being data.
    Himmler S; Stöckel J; van Exel J; Brouwer WBF
    Health Econ; 2021 Aug; 30(8):1849-1870. PubMed ID: 33951253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics and quality of pediatric cost-utility analyses.
    Kromm SK; Bethell J; Kraglund F; Edwards SA; Laporte A; Coyte PC; Ungar WJ
    Qual Life Res; 2012 Oct; 21(8):1315-25. PubMed ID: 22038397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.